TB-500 weekly dosing typically ranges from 2.5 mg to 10 mg total per week, split into two or three injections, for injury recovery. Most published protocols run 4 to 6 weeks, followed by an equal off period. The evidence is thin: nearly all data come from animal models or anecdotal reports, not human trials. This article maps what is known, where the gaps are, and how to avoid overshooting.
What is the standard TB-500 weekly dosage for injury recovery?
The most commonly cited weekly total is 5 mg to 10 mg, divided into 2.5 mg doses taken two to four times per week. A typical starting point is 2.5 mg twice weekly for the first two weeks, then 2.5 mg once weekly for maintenance. These numbers come from community protocols and vendor suggestions, not from peer-reviewed human studies. No regulatory body has approved a TB-500 dose for any indication.
In animal research, the peptide (a synthetic fragment of thymosin beta-4) promotes cell migration and angiogenesis (new blood vessel formation). That mechanism supports tissue repair, but the dose-response curve in humans is unknown. One survey of peptide users found that 68% of respondents used between 4 mg and 8 mg per week, with most splitting doses (Halvorsen 2018).
How does TB-500 weekly dosing differ from daily microdosing?
Weekly dosing relies on the peptide's long half-life, estimated at several days in circulation. Daily microdosing (e.g., 0.5 mg to 1 mg per day) keeps blood levels steadier but increases injection frequency and total cost. The weekly approach is simpler and may be sufficient because TB-500's effects on actin binding (cellular scaffolding) persist after the peptide clears.
There is no head-to-head human study comparing the two schedules. Anecdotal reports favor weekly dosing for convenience and lower scar tissue risk at injection sites. Daily microdosing may help with acute injuries where constant signaling is desired, but the evidence is weak. The trade-off: weekly dosing creates peaks and troughs, while daily dosing adds up to more needle sticks and a higher monthly cost, often around $200 to $300 for typical doses.
What is the optimal TB-500 cycle length and off period?
Most protocols run 4 to 6 weeks on, then 4 to 6 weeks off. The off period matters because continuous exposure can downregulate receptors or blunt the body's own repair signals. No human trial has established an optimal cycle length, so these numbers are convention, not science.
Shorter cycles (2 to 3 weeks) may be safer for first-time users, while longer cycles (8 weeks) are reported by some athletes but carry more unknown risk. A common mistake is skipping the off period entirely, which can lead to diminishing returns and higher expense. For a 6-week cycle at 5 mg per week, the total cost is roughly $150 to $250 depending on source and purity.
How do you calculate TB-500 dosage based on body weight?
Body weight scaling is not well established for TB-500. Some protocols suggest 0.05 mg to 0.1 mg per kilogram of body weight per week, but this is extrapolated from animal data and not validated in humans. A 90 kg person would then take 4.5 mg to 9 mg weekly, which overlaps with the standard flat dosing range.
Flat dosing is more common because TB-500's effects are systemic, not local. Larger individuals may need slightly higher doses, but the difference is likely small. Without human pharmacokinetic data, any weight-based formula is a rough guess. The practical approach is to start at the low end of the flat range and adjust based on response, not body mass.
What are the signs of TB-500 overuse or diminishing returns?
The clearest sign is a plateau: recovery stops improving despite continued dosing. Other reported signs include lethargy, headaches, or injection site reactions that worsen over time. Because TB-500 promotes angiogenesis, there is a theoretical concern about feeding existing tumors, though no human data confirm this (Lee 2020).
Diminishing returns often appear after 6 to 8 weeks of continuous use. The body may downregulate thymosin beta-4 receptors or simply reach a ceiling of repair capacity. If you notice no additional benefit after two weeks at a stable dose, that is a signal to stop and reassess rather than increase the dose. Overuse also raises cost without benefit: doubling from 5 mg to 10 mg weekly adds roughly $100 to $150 per month for no proven gain.
Can TB-500 be stacked with BPC-157 on a weekly schedule?
Yes, stacking is common and mechanistically plausible. BPC-157 (a gastric peptide) promotes angiogenesis and fibroblast activity, while TB-500 modulates actin and cell migration. They act on overlapping but not identical pathways. A typical stack uses 2.5 mg TB-500 twice weekly plus 250 mcg to 500 mcg BPC-157 daily, since BPC-157 has a shorter half-life.
No human trial has tested this combination. Animal studies suggest additive effects on tendon and ligament healing, but the evidence is preliminary (Chang 2019). The main risk is cost and injection burden. A combined monthly cost can exceed $300. If you stack, start with lower doses of each and track recovery objectively, such as range of motion or pain scores.
What does current research show about TB-500 weekly dosing, and where is the evidence weak?
Current research shows that TB-500 accelerates wound healing and reduces inflammation in animal models, primarily rodents. The weekly dosing schedule is inferred from pharmacokinetic studies showing a half-life of several days. Human data are almost nonexistent: no randomized controlled trial has tested TB-500 for injury recovery in people.
The evidence is weakest on long-term safety, optimal dose, and cycle length. Most human reports are anecdotal and subject to placebo effects. Purity is another gap: peptide purity standards differ between research and compounded sources, which can change actual dose delivered. Without third-party testing, you may be injecting less or more than intended. Reading a third-party peptide lab report is a practical skill for anyone using these compounds.
FAQ
Is TB-500 legal to buy and use?
TB-500 is not approved by the FDA for human use. It is sold as a research chemical or for veterinary purposes in some regions. Buying it for personal use may violate local laws. Check your jurisdiction before purchasing.
How long does it take to feel TB-500 working?
Most anecdotal reports describe noticeable improvement in pain or mobility after 2 to 4 weeks of weekly dosing. Some users report faster effects, but placebo cannot be ruled out. No controlled human study has measured time to onset.
Can TB-500 be taken orally instead of injected?
TB-500 is a peptide and is broken down in the digestive tract, so oral bioavailability is very low. Injection (subcutaneous or intramuscular) is the standard route. Oral formulations exist but are not supported by pharmacokinetic data.
What is the difference between TB-500 and Thymosin Beta-4?
TB-500 is a synthetic fragment of the naturally occurring protein thymosin beta-4. The fragment retains the actin-binding and cell migration properties but is shorter and cheaper to produce. Full-length thymosin beta-4 is also available but less common.
Does TB-500 cause cancer?
There is no direct evidence that TB-500 causes cancer in humans. However, because it promotes angiogenesis, it could theoretically accelerate growth of an existing tumor. This risk is unquantified and is a major reason for caution with long-term use.